The resolution underscores the importance of increased awareness regarding pulmonary fibrosis and aligns Virginia's recognition with the national effort led by the Pulmonary Fibrosis Foundation, which has designated September as national Pulmonary Fibrosis Awareness Month since 2012. The intention behind this recognition is to encourage state-wide activities that inform the public about the disease and its impacts while potentially influencing funding and support for research initiatives aimed at combating this deadly condition.
Summary
HJR78, introduced in January 2026, aims to designate September of each year as Pulmonary Fibrosis Awareness Month in Virginia. This resolution highlights the seriousness of pulmonary fibrosis, a lung-scarring disease that currently lacks a definitive cure and has limited treatment options. Acknowledging the significant challenges faced by patients, the bill seeks to raise awareness about the disease, which affects approximately 50,000 individuals annually in the United States. By formally recognizing this awareness month, HJR78 aims to foster public understanding and support for research efforts into treatment and possible cures.
Contention
While the resolution itself is largely non-controversial, potential points of contention could arise regarding funding for associated awareness programs and scientific research efforts. Stakeholders may raise concerns about whether adequate resources are being allocated to not only promote awareness but also to support patients and their families. Additionally, the effectiveness of designated awareness months in generating meaningful progress in public health initiatives could be scrutinized in discussions surrounding the resolution.
Designating the week of September 21 through 28, 2025, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.
Designating the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.